Loading…
Hosted by The Leukemia & Lymphoma Society · EN · 31 episodes
Established thought leaders with verified media credentials.
Being diagnosed with a blood cancer can make you feel like you are alone. The Bloodline with LLS is here to remind you that after a diagnosis, comes hope. Listen in as we speak with experts and patients who will guide us in understanding diagnosis, treatment, and the many resources available to blood cancer patients.
The Leukemia & Lymphoma Society hosts Clinical Trials - The Bloodline with LLS, a health show with 31 episodes published.
Behind every policy is a patient, caregiver, or family whose story helped make change possible. In this episode, we speak […] The post Making Your Voice Count: The Power of Patient Advocacy first appeared on The Bl
When you hear the word “aggressive,” it can feel overwhelming, but in diffuse large B-cell lymphoma (DLBCL), it can also […] The post Diffuse Large B-Cell Lymphoma (DLBCL): Breaking Down an Aggressive Lymphoma firs
What does a myelofibrosis (MF) diagnosis really mean, and how does it fit within a group of conditions called myeloproliferative […] The post Myelofibrosis (MF): More Options, More Hope first appeared on The Bloodl
Some people with chronic lymphocytic leukemia (CLL) may feel well day to day, but that doesn’t mean life stays the […] The post Chronic Lymphocytic Leukemia (CLL): Managing Treatment and Finding Balance first appea
Acute myeloid leukemia (AML) is a complex diagnosis, and it can be difficult to know what to expect in those […] The post Acute Myeloid Leukemia (AML): New Approaches For A Complex Diagnosis first appeared on The B
Multiple myeloma can feel unfamiliar and overwhelming at first, but today’s advances tell a much brighter story. In this episode, […] The post Facing Multiple Myeloma: A Guide to Choices, Care, and Confidence first
CAR T‑cell therapy is redefining what personalized cancer treatment can look like, offering real promise for patients and families. In […] The post Inside CAR T‑Cell Therapy: How Innovation Is Changing Lives first
Cutaneous T‑cell lymphoma (CTCL) is a rare condition that often raises important questions for patients and families. In this episode, […] The post Cutaneous T-Cell Lymphoma (CTCL): Illuminating a Brighter Path For
Curious about what’s new in the world of myelodysplastic syndromes (MDS)? We’re bringing you the latest insights straight from one […] The post The Bloodline Live! Myelodysplastic Syndromes (MDS) Updates in Researc
In this episode, we are joined by Dr. Abdulraheem Yacoub of The University of Kansas Cancer Center to discuss myeloproliferative […] The post After Diagnosis: Finding Hope with Myeloproliferative Neoplasms first ap
Trent Wang, MD Curious about CAR T-cell therapy? We went straight to the source for answers. In this episode, the LLS Patient Education team visited The University of Miami Sylvester Cancer Center to meet with Dr. Trent
Eytan Stein, MD Acute myeloid leukemia (AML) is one of the most aggressive blood cancers—but science is making real progress. In this episode, Dr. Eytan Stein of Memorial Sloan Kettering breaks down what makes AML so cha
Cesar Rodriguez, MD In this episode, we sit down with Dr. Cesar Rodriguez of Mount Sinai Hospital in New York, NY to discuss the evolving landscape of myeloma treatment. Groundbreaking innovations are bringing new hope t
Francine Foss, MD A Cutaneous T-cell Lymphoma (CTCL) diagnosis can raise many questions, from understanding symptoms to exploring treatment options. In this episode, we talk to Dr. Francine Foss of Yale University to bre
Bilal Abid, MD In this episode, we sit down with Dr. Bilal Abid from University of Texas Health Science Center in Houston to discuss how healthcare disparities have an effect on cancer care — especially when it comes to
Alison Loren, MD A stem cell transplant for blood cancer is just the beginning – what may come next for the patient can be a complex journey. In this episode, Dr. Alison Loren of the University of Pennsylvania discusses
William Shomali, MD Research continues to accelerate for myelodysplastic syndromes (MDS), giving hope to patients and their loved ones. In this episode, Dr. William Shomali of Stanford University dives into cutting-edge
Yasmin Karimi, MD Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma. Tune in as we chat with Dr. Yasmin Karimi from the University of Michigan about the latest breakthroughs in treatment, i
Chronic myelomonocytic leukemia (CMML) has been a challenging disease to tackle, historically treated with therapies meant for other conditions. But there’s a new wave of hope! Join us as Dr. Eric Padron of Moffit Cancer
Chronic myelomonocytic leukemia (CMML) has been a challenging disease to tackle, historically treated with therapies meant for other conditions. But there’s a new wave of hope! Join us as Dr. Eric Padron of Moffitt Cance
Elizabeth Stone
Senior Manager · Campanile College Tours
2 appearances on this show
Trent Wang
University of Miami Sylvester Cancer Center
1 appearance on this show
Eytan Stein
Memorial Sloan Kettering
1 appearance on this show
Cesar Rodriguez
Mount Sinai Hospital
1 appearance on this show
Francine Foss
Yale University
1 appearance on this show
Bilal Abid
University of Texas Health Science Center
1 appearance on this show
Alison Loren
University of Pennsylvania
1 appearance on this show
William Shomali
Stanford University
1 appearance on this show
Yasmin Karimi
University of Michigan
1 appearance on this show
Eric Padron
Moffitt Cancer Center
1 appearance on this show
Dr. Eric Padron
Moffitt Cancer Center
1 appearance on this show
Dr. Lee Greenberger
The Leukemia & Lymphoma Society
1 appearance on this show
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Clinical Trials - The Bloodline with LLS has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their health audience.
Clinical Trials - The Bloodline with LLS is hosted by The Leukemia & Lymphoma Society. The show is categorised under health (fitness) and has published 31 episodes.
Clinical Trials - The Bloodline with LLS has published 31 episodes.
Clinical Trials - The Bloodline with LLS regularly covers health, fitness, medicine. It sits in the health category, with a fitness focus.
Clinical Trials - The Bloodline with LLS is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Clinical Trials - The Bloodline with LLS hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Clinical Trials - The Bloodline with LLS average 41 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Clinical Trials - The Bloodline with LLS's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 4 days ago.